Global Isosorbide Mononitrate Market
Global Isosorbide Mononitrate Market

Isosorbide Mononitrate Comprehensive Study by Type (10 mg Tablet, 20 mg Tablet), Application (Angina Pectoris, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Players and Region - Global Market Outlook to 2025

Isosorbide Mononitrate Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Oct 2020 Edition 204 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Isosorbide Mononitrate Market Scope
Isosorbide mononitrate is a nitrate that dilates (widens) blood vessels, making it easier for blood to flow through them and easier for the heart to pump. Isosorbide mononitrate is used to prevent angina attacks. Isosorbide Mononitrate is a nitrate. It reduces the workload of the heart. As a result, the heart muscle does not need as much blood and oxygen supply.

The Isosorbide Mononitrate market study is segmented by Type (10 mg Tablet and 20 mg Tablet), by Application (Angina Pectoris and Others) and major geographies with country level break-up.

The market is fragmented with numerous players focusing on technique and quality of the product due to which the global Isosorbide Mononitrate market can witness an upsurge in the forecast period. Research Analyst at AMA estimates that Global Players will contribute to the maximum growth of Global Isosorbide Mononitrate market throughout the predicted period.

Teva Pharmaceutical Industries Ltd (Israel), Merck Group (United States), Nesher Pharmaceuticals (United States), Taj pharmaceutical (India), AMRI India (India), Intas Pharmaceuticals (India), Sandoz (Germany), Shandong Fangming Pharmaceutical Group (China) and ReYoung Pharmaceutical (China) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Isosorbide Mononitrate market by Type, Application and Region.

On the basis of geography, the market of Isosorbide Mononitrate has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In Sept 2018, Avet Pharmaceuticals Inc.announced the immediate availability of Isosorbide Mononitrate Extended-Release 30mg tablets. This launch adds to Avet’s robust portfolio of generic oral solid products and is an addition to Avet’s marketed Isosorbide Mononitrate ER 60mg tablets. Isosorbide Mononitrate is the AB-rated generic equivalent to the antianginal drug Imdur®. It is indicated for the prevention of angina pectoris due to coronary artery disease.


Market Trend
  • Rising Clinical Trials

Market Drivers
  • Prevention of Angina Pectoris caused by Coronary Artery Disease
  • Rising Number Patients Worldwide Related Chest Pain Problems

Opportunities
  • Rising Demand from Emerging Economics such as India, China, and Others
  • Increasing Number of Cholesterol, Heart Attack Related Patients

Restraints
  • Common Side Effects of Isosorbide Mononitrate Headache, Dizziness, Flushing, Orthostatic hypotension (sudden lowering of blood pressure on standing)

Challenges
  • Lack of Awareness Regarding the Benefit of Isosorbide Mononitrate


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Isosorbide Mononitrate Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • 10 mg Tablet
  • 20 mg Tablet
By Application
  • Angina Pectoris
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Prevention of Angina Pectoris caused by Coronary Artery Disease
      • 3.2.2. Rising Number Patients Worldwide Related Chest Pain Problems
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness Regarding the Benefit of Isosorbide Mononitrate
    • 3.4. Market Trends
      • 3.4.1. Rising Clinical Trials
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Isosorbide Mononitrate, by Type, Application, Distribution Channel and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Isosorbide Mononitrate (Value)
      • 5.2.1. Global Isosorbide Mononitrate by: Type (Value)
        • 5.2.1.1. 10 mg Tablet
        • 5.2.1.2. 20 mg Tablet
      • 5.2.2. Global Isosorbide Mononitrate by: Application (Value)
        • 5.2.2.1. Angina Pectoris
        • 5.2.2.2. Others
      • 5.2.3. Global Isosorbide Mononitrate by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacies
        • 5.2.3.2. Retail Pharmacies
        • 5.2.3.3. Online Pharmacies
      • 5.2.4. Global Isosorbide Mononitrate Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Isosorbide Mononitrate: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Teva Pharmaceutical Industries Ltd (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Group (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nesher Pharmaceuticals (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Taj pharmaceutical (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AMRI India (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Intas Pharmaceuticals (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sandoz (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Shandong Fangming Pharmaceutical Group (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ReYoung Pharmaceutical (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Isosorbide Mononitrate Sale, by Type, Application, Distribution Channel and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Isosorbide Mononitrate (Value)
      • 7.2.1. Global Isosorbide Mononitrate by: Type (Value)
        • 7.2.1.1. 10 mg Tablet
        • 7.2.1.2. 20 mg Tablet
      • 7.2.2. Global Isosorbide Mononitrate by: Application (Value)
        • 7.2.2.1. Angina Pectoris
        • 7.2.2.2. Others
      • 7.2.3. Global Isosorbide Mononitrate by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacies
        • 7.2.3.2. Retail Pharmacies
        • 7.2.3.3. Online Pharmacies
      • 7.2.4. Global Isosorbide Mononitrate Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Isosorbide Mononitrate: by Type(USD Million)
  • Table 2. Isosorbide Mononitrate 10 mg Tablet , by Region USD Million (2014-2019)
  • Table 3. Isosorbide Mononitrate 20 mg Tablet , by Region USD Million (2014-2019)
  • Table 4. Isosorbide Mononitrate: by Application(USD Million)
  • Table 5. Isosorbide Mononitrate Angina Pectoris , by Region USD Million (2014-2019)
  • Table 6. Isosorbide Mononitrate Others , by Region USD Million (2014-2019)
  • Table 7. Isosorbide Mononitrate: by Distribution Channel(USD Million)
  • Table 8. Isosorbide Mononitrate Hospital Pharmacies , by Region USD Million (2014-2019)
  • Table 9. Isosorbide Mononitrate Retail Pharmacies , by Region USD Million (2014-2019)
  • Table 10. Isosorbide Mononitrate Online Pharmacies , by Region USD Million (2014-2019)
  • Table 11. South America Isosorbide Mononitrate, by Country USD Million (2014-2019)
  • Table 12. South America Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 13. South America Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 14. South America Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 15. Brazil Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 16. Brazil Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 17. Brazil Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 18. Argentina Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 19. Argentina Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 20. Argentina Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 21. Rest of South America Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 22. Rest of South America Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 23. Rest of South America Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 24. Asia Pacific Isosorbide Mononitrate, by Country USD Million (2014-2019)
  • Table 25. Asia Pacific Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 26. Asia Pacific Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 27. Asia Pacific Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 28. China Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 29. China Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 30. China Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 31. Japan Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 32. Japan Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 33. Japan Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 34. India Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 35. India Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 36. India Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 37. South Korea Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 38. South Korea Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 39. South Korea Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 40. Taiwan Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 41. Taiwan Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 42. Taiwan Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 43. Australia Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 44. Australia Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 45. Australia Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 46. Rest of Asia-Pacific Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 47. Rest of Asia-Pacific Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 48. Rest of Asia-Pacific Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 49. Europe Isosorbide Mononitrate, by Country USD Million (2014-2019)
  • Table 50. Europe Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 51. Europe Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 52. Europe Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 53. Germany Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 54. Germany Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 55. Germany Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 56. France Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 57. France Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 58. France Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 59. Italy Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 60. Italy Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 61. Italy Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 62. United Kingdom Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 63. United Kingdom Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 64. United Kingdom Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 65. Netherlands Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 66. Netherlands Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 67. Netherlands Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 68. Rest of Europe Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 69. Rest of Europe Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 70. Rest of Europe Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 71. MEA Isosorbide Mononitrate, by Country USD Million (2014-2019)
  • Table 72. MEA Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 73. MEA Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 74. MEA Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 75. Middle East Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 76. Middle East Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 77. Middle East Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 78. Africa Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 79. Africa Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 80. Africa Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 81. North America Isosorbide Mononitrate, by Country USD Million (2014-2019)
  • Table 82. North America Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 83. North America Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 84. North America Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 85. United States Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 86. United States Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 87. United States Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 88. Canada Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 89. Canada Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 90. Canada Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 91. Mexico Isosorbide Mononitrate, by Type USD Million (2014-2019)
  • Table 92. Mexico Isosorbide Mononitrate, by Application USD Million (2014-2019)
  • Table 93. Mexico Isosorbide Mononitrate, by Distribution Channel USD Million (2014-2019)
  • Table 94. Company Basic Information, Sales Area and Its Competitors
  • Table 95. Company Basic Information, Sales Area and Its Competitors
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Isosorbide Mononitrate: by Type(USD Million)
  • Table 104. Isosorbide Mononitrate 10 mg Tablet , by Region USD Million (2020-2025)
  • Table 105. Isosorbide Mononitrate 20 mg Tablet , by Region USD Million (2020-2025)
  • Table 106. Isosorbide Mononitrate: by Application(USD Million)
  • Table 107. Isosorbide Mononitrate Angina Pectoris , by Region USD Million (2020-2025)
  • Table 108. Isosorbide Mononitrate Others , by Region USD Million (2020-2025)
  • Table 109. Isosorbide Mononitrate: by Distribution Channel(USD Million)
  • Table 110. Isosorbide Mononitrate Hospital Pharmacies , by Region USD Million (2020-2025)
  • Table 111. Isosorbide Mononitrate Retail Pharmacies , by Region USD Million (2020-2025)
  • Table 112. Isosorbide Mononitrate Online Pharmacies , by Region USD Million (2020-2025)
  • Table 113. South America Isosorbide Mononitrate, by Country USD Million (2020-2025)
  • Table 114. South America Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 115. South America Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 116. South America Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 117. Brazil Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 118. Brazil Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 119. Brazil Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 120. Argentina Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 121. Argentina Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 122. Argentina Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 123. Rest of South America Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 124. Rest of South America Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 125. Rest of South America Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 126. Asia Pacific Isosorbide Mononitrate, by Country USD Million (2020-2025)
  • Table 127. Asia Pacific Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 128. Asia Pacific Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 129. Asia Pacific Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 130. China Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 131. China Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 132. China Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 133. Japan Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 134. Japan Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 135. Japan Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 136. India Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 137. India Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 138. India Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 139. South Korea Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 140. South Korea Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 141. South Korea Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 142. Taiwan Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 143. Taiwan Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 144. Taiwan Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 145. Australia Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 146. Australia Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 147. Australia Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 148. Rest of Asia-Pacific Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 149. Rest of Asia-Pacific Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 150. Rest of Asia-Pacific Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 151. Europe Isosorbide Mononitrate, by Country USD Million (2020-2025)
  • Table 152. Europe Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 153. Europe Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 154. Europe Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 155. Germany Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 156. Germany Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 157. Germany Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 158. France Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 159. France Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 160. France Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 161. Italy Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 162. Italy Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 163. Italy Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 164. United Kingdom Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 165. United Kingdom Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 166. United Kingdom Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 167. Netherlands Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 168. Netherlands Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 169. Netherlands Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 170. Rest of Europe Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 171. Rest of Europe Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 172. Rest of Europe Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 173. MEA Isosorbide Mononitrate, by Country USD Million (2020-2025)
  • Table 174. MEA Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 175. MEA Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 176. MEA Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 177. Middle East Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 178. Middle East Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 179. Middle East Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 180. Africa Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 181. Africa Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 182. Africa Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 183. North America Isosorbide Mononitrate, by Country USD Million (2020-2025)
  • Table 184. North America Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 185. North America Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 186. North America Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 187. United States Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 188. United States Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 189. United States Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 190. Canada Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 191. Canada Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 192. Canada Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 193. Mexico Isosorbide Mononitrate, by Type USD Million (2020-2025)
  • Table 194. Mexico Isosorbide Mononitrate, by Application USD Million (2020-2025)
  • Table 195. Mexico Isosorbide Mononitrate, by Distribution Channel USD Million (2020-2025)
  • Table 196. Research Programs/Design for This Report
  • Table 197. Key Data Information from Secondary Sources
  • Table 198. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Isosorbide Mononitrate: by Type USD Million (2014-2019)
  • Figure 5. Global Isosorbide Mononitrate: by Application USD Million (2014-2019)
  • Figure 6. Global Isosorbide Mononitrate: by Distribution Channel USD Million (2014-2019)
  • Figure 7. South America Isosorbide Mononitrate Share (%), by Country
  • Figure 8. Asia Pacific Isosorbide Mononitrate Share (%), by Country
  • Figure 9. Europe Isosorbide Mononitrate Share (%), by Country
  • Figure 10. MEA Isosorbide Mononitrate Share (%), by Country
  • Figure 11. North America Isosorbide Mononitrate Share (%), by Country
  • Figure 12. Global Isosorbide Mononitrate share by Players 2019 (%)
  • Figure 13. Global Isosorbide Mononitrate share by Players (Top 3) 2019(%)
  • Figure 14. Global Isosorbide Mononitrate share by Players (Top 5) 2019(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Teva Pharmaceutical Industries Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 17. Teva Pharmaceutical Industries Ltd (Israel) Revenue: by Geography 2019
  • Figure 18. Merck Group (United States) Revenue, Net Income and Gross profit
  • Figure 19. Merck Group (United States) Revenue: by Geography 2019
  • Figure 20. Nesher Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 21. Nesher Pharmaceuticals (United States) Revenue: by Geography 2019
  • Figure 22. Taj pharmaceutical (India) Revenue, Net Income and Gross profit
  • Figure 23. Taj pharmaceutical (India) Revenue: by Geography 2019
  • Figure 24. AMRI India (India) Revenue, Net Income and Gross profit
  • Figure 25. AMRI India (India) Revenue: by Geography 2019
  • Figure 26. Intas Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 27. Intas Pharmaceuticals (India) Revenue: by Geography 2019
  • Figure 28. Sandoz (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Sandoz (Germany) Revenue: by Geography 2019
  • Figure 30. Shandong Fangming Pharmaceutical Group (China) Revenue, Net Income and Gross profit
  • Figure 31. Shandong Fangming Pharmaceutical Group (China) Revenue: by Geography 2019
  • Figure 32. ReYoung Pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 33. ReYoung Pharmaceutical (China) Revenue: by Geography 2019
  • Figure 34. Global Isosorbide Mononitrate: by Type USD Million (2020-2025)
  • Figure 35. Global Isosorbide Mononitrate: by Application USD Million (2020-2025)
  • Figure 36. Global Isosorbide Mononitrate: by Distribution Channel USD Million (2020-2025)
  • Figure 37. South America Isosorbide Mononitrate Share (%), by Country
  • Figure 38. Asia Pacific Isosorbide Mononitrate Share (%), by Country
  • Figure 39. Europe Isosorbide Mononitrate Share (%), by Country
  • Figure 40. MEA Isosorbide Mononitrate Share (%), by Country
  • Figure 41. North America Isosorbide Mononitrate Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Merck Group (United States)
  • Nesher Pharmaceuticals (United States)
  • Taj pharmaceutical (India)
  • AMRI India (India)
  • Intas Pharmaceuticals (India)
  • Sandoz (Germany)
  • Shandong Fangming Pharmaceutical Group (China)
  • ReYoung Pharmaceutical (China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation